Option chain shows key data for Greenlane Hldgs's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Greenlane Hldgs.

Greenlane Hldgs (NASDAQ:GNLN) Stock, Option Chain

Greenlane Hldgs

Greenlane Holdings Inc is a distributor of vaporization products and consumption accessories in the United States. It offers a selection of stock-keeping units including vaporizers and parts, cleaning products, grinders and storage containers, pipes, rolling papers and customized lines of premium specialty packaging. The company markets and sells its products in both the business to business and business to consumer sectors of the marketplace. Its geographical segment includes the United States; Canada and Europe. It derives a majority of revenue from the United States.

cannabis money, cannabis earnings, marijuana money, buds, money

Cannabis

Earnings

News

GNLN

Greenlane Cuts Q3 Net Loss Despite 66% Revenue Drop, Shifts Product Strategy

Nikola Motor

Intraday Update

Markets

Movers

Trading Ideas

ALTS

ALZN

APDN

APPS

CING

CLOV

FFIE

FHTX

FUBO

GOVX

IBRX

INZY

LLAP

LQDA

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

NKLA

SEEL

SIDU

SOND

TELO

TGTX

TNXP

TOVX

VALN

VRAX

XPER

ZVRA

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

AI Generated Image 

Biotech

Emerging Markets

Entrepreneurship

Contracts

Retail Sales

Management

Success Stories

Exclusives

Tech

Interview

General

Synergy Innovation, recently launched as a house of brands, is making waves in the cannabis accessories sector with its acquisition of DaVinci and Eyce. This new venture marks a significant return to original ownership for these brands.

Tony Stark&#39;s Choice Vape? Synergy Innovation&#39;s Strategic Move To Restore Brands&#39; Identity, Lead Market Niche

Greenlane Holdings, Inc. - Class A Common Stock

Greenlane Holdings Inc

Positive Reimbursement&nbsp;Recommendations&nbsp;by Canada's Drug Agency and Institut National d'excellence en Santé et Services Sociaux

Reported Sunday, Takeda's FRUZAQLA (fruquintinib) Receives Health Canada Approval For Metastatic Colorectal Cancer

<h3>Companies Reporting Before The Bell</h3>
• 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) is estimated to report quarterly earnings at $1.66 per share on revenue of $5.78 billion. 
• United Microelectronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMC#NYSE">UMC</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $1.87 billion. 
• Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) is expected to report quarterly loss at $0.21 per share on revenue of $76.50 million. 
• Old National (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) is estimated to report quarterly earnings at $0.46 per share on revenue of $485.57 million. 
• Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>) is projected to report quarterly earnings at $0.88 per share on revenue of $2.21 billion. 
• FB Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBK#NYSE">FBK</a>) is estimated to report quarterly earnings at $0.83 per share on revenue of $131.14 million. 
• KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) is projected to report quarterly earnings at $0.32 per share on revenue of $1.75 billion. 
• Mercantile Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBWM#NASDAQ">MBWM</a>) is projected to report quarterly earnings at $1.14 per share on revenue of $57.33 million. 
• Prologis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>) is projected to report quarterly earnings at $1.38 per share on revenue of $1.94 billion. 
• Guaranty Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNTY#NYSE">GNTY</a>) is expected to report quarterly earnings at $0.61 per share on revenue of $29.49 million. 
• Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) is likely to report quarterly earnings at $0.89 per share on revenue of $5.13 billion. 
• Peoples Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEBO#NASDAQ">PEBO</a>) is estimated to report quarterly earnings at $0.75 per share on revenue of $109.93 million. 
• Forestar Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOR#NYSE">FOR</a>) is estimated to report quarterly earnings at $0.70 per share on revenue of $328.44 million. 
• New Oriental Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $1.06 billion. 
• Community Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBU#NYSE">CBU</a>) is projected to report quarterly earnings at $0.89 per share on revenue of $192.78 million. 
• D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) is estimated to report quarterly earnings at $2.39 per share on revenue of $7.12 billion. 
<h3>Companies Reporting After The Bell</h3>
• Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) is estimated to report quarterly earnings at $1.26 per share on revenue of $787.50 million. 
• United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) is expected to report quarterly earnings at $3.01 per share on revenue of $14.34 billion. 
• SmartFinancial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMBK#NYSE">SMBK</a>) is projected to report quarterly earnings at $0.50 per share on revenue of $44.37 million. 
• Simmons First Ntl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFNC#NASDAQ">SFNC</a>) is likely to report quarterly earnings at $0.35 per share on revenue of $208.67 million. 
• Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) is likely to report quarterly earnings at $4.20 per share on revenue of $10.13 billion. 
• Trustco Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRST#NASDAQ">TRST</a>) is likely to report earnings for its fourth quarter. 
• Progress Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRGS#NASDAQ">PRGS</a>) is likely to report quarterly earnings at $1.22 per share on revenue of $211.34 million. 
• Interactive Brokers Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) is projected to report quarterly earnings at $1.82 per share on revenue of $1.37 billion. 
• Hancock Whitney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWC#NASDAQ">HWC</a>) is likely to report quarterly earnings at $1.28 per share on revenue of $365.13 million. 
• Pinnacle Finl Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNFP#NASDAQ">PNFP</a>) is expected to report quarterly earnings at $1.78 per share on revenue of $470.83 million. 
• Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) is estimated to report quarterly earnings at $0.34 per share on revenue of $73.15 million. 
• Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) is expected to report quarterly earnings at $1.87 per share on revenue of $2.32 billion. 
• Pathward Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASH#NASDAQ">CASH</a>) is expected to report quarterly earnings at $1.24 per share on revenue of $171.35 million. 
• Fulton Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULT#NASDAQ">FULT</a>) is projected to report quarterly earnings at $0.42 per share on revenue of $315.73 million. 
• Great Southern Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSBC#NASDAQ">GSBC</a>) is expected to report quarterly earnings at $1.32 per share on revenue of $55.33 million. 
• Wintrust Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>) is projected to report quarterly earnings at $2.49 per share on revenue of $632.53 million. 
• Capital One Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) is projected to report quarterly earnings at $2.71 per share on revenue of $10.21 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AGYS

CASH

CSLR

New Oriental Education & Technology Group

FITB

FULT

GNTY

GSBC

IBKR

MBWM

NFLX

PEBO

PNFP

PRGS

SCHW

SFNC

SMBK

TRST

WTFC

ZION

Earnings Scheduled For January 21, 2025

UHAL

Reported Sunday, U-Haul Adds Climate-Controlled Storage Units In Marietta With New Two-Story Facility

Customers in the U.S. looking to purchase an electric vehicle can get a $7500 federal EV tax credit for several models including from Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), and more. However, President Donald Trump on Monday said that his administration would consider ending tax credits, impacting the purchase price for eligible customers.
Vehicles That Qualify: The various Tesla electric vehicles eligible for $7,500 include select trims of the Cybertruck, Model 3, Model X, and Model Y. Other brand vehicles that qualify include the Kia EV9 and selected trims of the F-150 Lightning truck.
The only Plug-in Hybrid that qualifies for the credit is the Chrysler Pacifica PHEV.
The list of vehicles that qualify for the tax credit right now is as follows:
<ul>
<li>Acura ZDX</li>
<li>Cadillac Lyriq (Luxury and Sport Models)</li>
<li>Cadillac Optiq</li>
<li>Chevrolet Blazer EV (LT, RS, and SS Models)</li>
<li>Chevrolet Equinox EV (LT and RS Models)</li>
<li>Chevrolet Silverado EV (LT Model)</li>
<li>Ford F-150 Lightning (Flash, Lariat and XLT Trims)</li>
<li>Honda Prologue</li>
<li>Jeep Wagoneer S</li>
<li>Kia EV6</li>
<li>Kia EV9</li>
<li>Tesla Cybertruck (Single Motor and Dual Motor)</li>
<li>Tesla Model 3 (Long Range AWD, Long Range RWD, Performance variants)</li>
<li>Tesla Model X (AWD Variant)</li>
<li>Tesla Model Y (Long Range AWD, Long Range RWD, Performance variants)</li>
<li>Chrysler Pacifica PHEV</li>
</ul>
Trump&#8217;s Take On EV Tax Credits: In November, Reuters reported that Donald Trump‘s transition team plans to kill the $7,500 tax credit available on EV purchases. On Monday, after his inauguration, Trump himself said his administration would consider ending EV tax credits.
&#8220;The Republicans have a very small majority in the House, which could make it hard for the party to pass legislation of any kind,&#8221; The Future Fund Managing Partner Gary Black said about a possible repeal of the tax credit on Monday. &#8220;Another wild card is Elon Musk, with $TSLA accounting for nearly half of all EVs sold in the country. With Elon Musk close to the president, it is important to know how he will seek to shape changes to the tax credit. Other auto executives have also been lobbying Mr. Trump against a repeal of the credit. Among them is Ford's executive chairman, William C. Ford Jr., who recently spoke to the president-elect.&#8221;
However, Tesla CEO Elon Musk, a close Trump ally, has previously supported scrapping of the tax credit. 
"In my view, we should end all government subsidies, including those for EVs, oil and gas," Musk said in November.
During Tesla&#8217;s second-quarter earnings in late July, Musk also said that the impact of the elimination of subsidies&nbsp;<a href="https://www.benzinga.com/news/24/07/39934750/trump-presidency-and-ira-cut-would-be-devastating-for-competitors-says-elon-musk-long-term-probably" target="_blank" rel="noreferrer noopener">would only be slight for Tesla</a>&nbsp;but devastating for its competitors. The elimination of EV subsidies would probably help Tesla in the long term, he added.
However, not all are in agreement. Tesla researcher Troy Teslike has previously said that the loss of tax credit will only make Tesla<a href="https://www.benzinga.com/24/12/42641207/researcher-says-cancelation-of-7500-ev-tax-credit-could-impact-teslas-deliveries-despite-ceo-elon-musk-claiming-otherwise" target="_blank" rel="noreferrer noopener">&nbsp;lose its market to gas cars</a>&nbsp;from luxury car brands.
Trump, on Monday also revoked a 2021 executive order signed by former President Joe Biden that sought to ensure that 50% of new vehicles sold in the U.S. by 2020 are electric.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43080738/nhtsa-opens-probe-into-about-878000-gm-gas-vehicles-days-after-closing-investigation-into-its-cruise-avs" target="_blank" rel="noreferrer noopener">NHTSA Opens Probe Into Nearly 878,000 GM Vehicles Over Engine Failure Concerns Days After Closing Investigation Into Its Cruise AVs</a></li>
</ul>
Photo courtesy: Shutterstock

TSLA

Here Are The EVs Which Could Lose $7,500 EV Tax Credit Under Trump Administration

Amcon Distributing (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DIT#AMEX">DIT</a>) reported quarterly earnings of $0.57 per share. This is a 67.98 percent decrease over earnings of $1.78 per share from the same period last year. The company reported $711.27 million in sales this quarter. This is a 10.28 percent increase over sales of $644.96 million the same period last year.

Reported Monday, Amcon Distributing Q1 EPS $0.57 Down From $1.78 YoY, Sales $711.27M Up From $644.96M YoY

<ul>
<li>Significant portfolio expansion to include combat-proven autonomous airborne platforms in support of critical forward-looking national security mission needs</li>
<li>Expected to be immediately accretive to Revenue, Adjusted EBITDA and Free Cash Flow</li>
<li>Post-transaction, Redwire expects to have a strong balance sheet</li>
</ul>

Reported Sunday, Redwire To Acquire Edge Autonomy In $925M Deal, Transforming Into A Multi-Domain Space And Defense Leader

Collaboration will bring bespoke content and never-before-seen show integrations

Reported Sunday, BetMGM Secures Online Casino Rights For Fremantle's "Family Feud" And "The Price Is Right"

Programming Already Restored for Two Million Viewers, Including NFL Playoff Games and Local News

ATUS

NXST

Reported Saturday, Nexstar And Optimum Reach Agreement To Restore Programming For Two Million Customers

<a href="https://www.globenewswire.com/Tracker?data=ZJKetO8zE3erzqRGF_P7-sCgwYhySBueJMgNqynfM3aNltyVHIqgYbS_u8Uz3Nv7SKdETdCLI16Ppo7Wvc4v8A==">NANOBIOTIX</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBTX#NASDAQ">NBTX</a>), a late-clinical stage biotechnology company pioneering nanoparticle-based therapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced that the first patient has been dosed in the CONVERGE study, a Phase 2 randomized controlled clinical trial evaluating potential first-in-class radioenhancer JNJ-1900 (NBTXR3) for the treatment of patients with Stage 3 unresectable non-small cell lung cancer receiving standard of care chemoradiation followed by consolidation durvalumab (<a href="https://www.globenewswire.com/Tracker?data=9AF1jPR-HWZ8jVuLKKF7MX10tUChZ_X2NGuXvAVUyFwhfw23CgjxX9aY63wN0Kdaec4QfEQsIuazNYZjxTvGX2JHp8IO-l0T8OXn7FrEKgkLxinTtGOoP8RlFCRY0HK-ieJqCKDibtD2Daq_RvrOBA==">NCT06667908</a>). CONVERGE is sponsored by Janssen Pharmaceutica NV, a Johnson &amp; Johnson Company, under a global license agreement.

NBTX

Nanobiotix Begins Phase 2 Trial for Innovative Cancer Treatment in Stage 3 Lung Cancer

ARBK

Argo Blockchain CEO Thomas Chippas To Exit; CFO Jim MacCallum Appointed As Interim Successor

The Charles Schwab Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) will release its fourth-quarter financial results, before the <a href="https://www.benzinga.com/quote/SCHW/earnings">opening bell, on Tuesday, Jan. 21, 2025.</a>
Analysts expect the Westlake, Texas-based company to report quarterly earnings at 91 cents per share, up from 68 cents per share in the year-ago period. Charles Schwab projects quarterly revenue of $5.2 billion, compared to $4.46 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Dec. 13, Charles Schwab said it expects FY24 net revenue to grow by 3.0%-3.5% versus the prior year.
Charles Schwab shares gained 1.2% to close at $76.41 on Friday&nbsp;&nbsp;&nbsp; .
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/SCHW/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Wells Fargo analyst Michael Brown maintained an Equal-Weight rating and cut the price target from $90 to $89 on Jan. 14, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Citigroup analyst Christopher Allen maintained a Neutral rating and cut the price target from $85 to $80 on Jan. 10, 2025. This analyst has an accuracy rate of 77%.</li>
<li>JP Morgan analyst Kenneth Worthington maintained an Overweight rating and raised the price target from $87 to $93 on Jan. 7, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Piper Sandler analyst Patrick Moley maintained a Neutral rating and raised the price target from $65 to $70 on Jan. 7, 2025. This analyst has an accuracy rate of 81%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintained an Outperform rating and raised the price target from $81 to $93 on Dec. 20, 2024. This analyst has an accuracy rate of 65%.</li>
</ul>
Considering buying SCHW stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/20040940/image-124-1024x576.png" alt="" class="wp-image-741030" style="width:574px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/20040940/image-124-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/20040940/image-124-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/20040940/image-124-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/20040940/image-124.png 1132w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43054647/wall-streets-most-accurate-analysts-spotlight-on-3-financial-stocks-with-over-9-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Financial Stocks With Over 9% Dividend Yields</a></li>
</ul>

Price Target

Pre-Market Outlook

Analyst Ratings

Charles Schwab Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

GOEV

Reported Friday, Canoo Announces Chapter 7 Bankruptcy Filing, Ending Operations Effective Immediately

SPPL

Reported Friday, SIMPPLE Receives Nasdaq Notifications For Minimum Equity And Annual Meeting Deficiencies

Macro Economic Events

Econ #s

Economics

U.K. Unemployment Rate For November 4.4% Vs. 4.3% Est.; 4.3% Prior

U.K. Employment Change 3M/3M (MoM) For November 35K Vs. 35K Est.; 173K Prior

U.K. Claimant Count Change For December 0.7K Vs. 10.3K Est.; -25.1K (Revised) Prior

U.K. Average Earnings Index +Bonus For November 5.6% Vs. 5.6% Est.; 5.2% Prior

<ul>
<li>Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function</li>
<li>The transdermal GFR (tGFR) methodology has been designed to be effective across the adult population without input of age, weight, sex, gender, race, or ethnicity</li>
<li>More than 800 million people have Chronic Kidney Disease (CKD), one of the world's leading causes of mortality worldwide, with associated deaths increasing over the past two decades1</li>
</ul>

VATE

Reported Friday, INNOVATE Announces FDA Approval Of MediBeacon's TGFR System For Accurate Kidney Function Testing

MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares dropped 2.35% in overnight trading on Robinhood Markets on Tuesday, falling to $386.80 as cryptocurrency markets reacted to President Donald Trump&#8216;s inauguration speech that notably <a href="https://www.benzinga.com/25/01/43086698/crypto-market-plunges-after-trumps-inaugural-speech-fails-to-mention-digital-assets">omitted any mention of digital assets</a>.
What Happened: The enterprise software company, which holds over $45 billion in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), had seen its stock surge 8.04% to $396.50 on Friday amid optimism about Trump&#8217;s anticipated crypto-friendly policies. 
The company&#8217;s executive chairman Michael Saylor attended a &#8220;Crypto Ball&#8221; last Friday where he met with Trump&#8217;s incoming cabinet members, fueling speculation about <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43078515/michael-saylor-meets-trumps-cabinet-at-crypto-ball-what-does-the-bitcoin-bulls-cryptic-post-indicate">favorable cryptocurrency regulations</a>.
However, Trump&#8217;s inaugural address focused instead on traditional assets, declaring the start of a &#8220;Golden Age of America&#8221; &#8211; a reference that prompted Bitcoin critic Peter Schiff to highlight the president&#8217;s apparent preference for gold over cryptocurrency. 
See Also: <a href="https://www.benzinga.com/25/01/43088034/bitcoin-ethereum-dogecoin-retrace-from-pre-inauguration-highs-as-trumps-address-disappoints-analyst-highlights-possibility-of-btc-consolidation-in-101k-106k-range">Bitcoin, Ethereum, Dogecoin Retrace From Pre-Inauguration Highs As Trump Skips Crypto Mention: Analyst Highlights BTC Consolidation In $101K-$106K Range</a>
Why It Matters: The speech&#8217;s omission of digital assets triggered a broader <a href="https://www.benzinga.com/25/01/43088563/bitcoin-vs-gold-peter-schiff-decodes-trumps-golden-age-reference-in-inaugural-speech">crypto market decline</a>, with Bitcoin falling from $106,000 to $101,775.
The selloff comes as Trump named Mark Uyeda as acting U.S. Securities and Exchange Commission chair, replacing Gary Gensler. 
The firm has been purchasing Bitcoin for ten consecutive weeks, according to its public disclosures.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43088840/donald-and-melania-trump-memecoins-crash-after-presidential-inaugurationfirst-couples-crypto-wealth-plunges-36">Donald And Melania Trump Memecoins Crash, Erode Billions In Investors&#8217; Wealth</a></li>
</ul>
Image Via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

$BTC

MSTR

MicroStrategy Drop 2.35% On Overnight Trading After Trump's Inauguration Speech Sidelines Cryptocurrency, Bitcoin Retreats Below $102K

Uniti intends to use the net proceeds of the offering to, among other things, repay and terminate its existing ABS bridge facility and for general corporate purposes, which may include success-based capital investments and/or repayment of outstanding debt.

UNIT

Reported Friday, Uniti Group Prices $589M Fiber Securitization Notes Secured By Florida And Gulf Coast Assets With 2030 Repayment Target

Greenlane (GNLN) Holdings has signed an exclusive multi-year global distributor agreement with CURB Lifestyle, manufacturer of a patented, non-heat...

Greenlane signs multi-year distributor agreement with CURB Lifestyle

Greenlane (GNLN) Holdings has begun distribution of Toxi Shield by Safety Strips' premium quality and competitively priced iodine tablets produced ...

Greenlane begins distribution of Toxi Shield by Safety Strip's iodine tablets

Greenlane (GNLN) announced that Rob Shields has been appointed to the new role of Greenlane's Chief Growth Officer. n his new role, Shields will le...

Greenlane appoints Rob Shields as CGO

In this week's "Rising High," The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on a default on rent ob...

Rising High: Innovative Industrial reports PharmaCann default

The latest update is out from Greenlane Holdings ( ($GNLN) ). Greenlane Holdings has appointed Rob Shields as its new Chief Growth Officer, effecti...

Greenlane Holdings Appoints Rob Shields as Growth Officer

Greenlane signs distribution agreement with Green Gruff USA

Greenlane (GNLN) Holdings has entered into a new exclusive U.S. distribution agreement with Green Gruff USA. Grenn Gruff offers a comprehensive lin...

Greenlane enters distribution agreement with Green Gruff USA

An announcement from Greenlane Holdings ( ($GNLN) ) is now available. Greenlane Holdings announced the appointment of Barbara Sher and Michael C. H...

Greenlane Holdings Announces Board Appointments and Approvals

Greenlane regains full compliance with Nasdaq continued listing rules

Greenlane (GNLN) Holdings has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requires Nasdaq listed companies to maintain an audit ...

Greenlane regains compliance with Nasdaq listing rules

ATAI

CMND

CMPS

CRON

CVSI

GTBIF

IIPR

ITHUF

LOWLF

MNMD

TCNNF

TLRY

VREOF

Press Releases

Greenlane Announces Non-Binding Letter of Intent to Distribute the CURB Lifestyle, Inc. Breakthrough Inhalation Device Technology for Nicotine, Cannabinoids and Other Wellness Compounds

Greenlane Announces Exclusive Distribution Agreement with Safety Strips Tech Corp Fentanyl, Xylazine and Drink Spike Detection Test Strips

Greenlane Reports Third Quarter 2024 Financial Results

Greenlane Signs New U.S. Distribution Agreement with Veriteque USA, Manufacturer of the SwabTek(TM) and Verifique(TM) Brand of Field Test Kits

Greenlane Signs Exclusive Global Multi-Year Global Agreement to Distribute the CURB Lifestyle, Inc. Breakthrough Inhalation Device Technology for Nicotine, Cannabinoids and Other Wellness Compounds

Greenlane Continues Product Diversification Strategy with Additional Homeland Security and Health Safety Product Offering

Greenlane Appoints Rob Shields as Chief Growth Officer

CORRECTION FROM SOURCE: Greenlane Appoints Rob Shields as Chief Growth Officer

Greenlane Signs New Exclusive U.S. Distribution Agreement with Green Gruff USA Inc.

Comments

Greenlane Hldgs

Greenlane Hldgs (GNLN) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga